Jane Henderson - Jul 13, 2023 Form 3/A - Amendment Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Chief Financial Officer
Signature
/s/ Jane Henderson
Stock symbol
APGE
Transactions as of
Jul 13, 2023
Transactions value $
$0
Form type
3/A - Amendment
Date filed
7/17/2023, 05:05 PM
Date Of Original Report
Jul 13, 2023
Previous filing
Jul 13, 2023
Next filing
Dec 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding APGE Common Stock 207K Jul 13, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 206,871 shares of restricted common stock, one quarter of which will vest on February 1, 2024, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer.
F2 This amendment is being filed to correct the number of shares reported in Table I due to a calculation error.